Back
45
41
25
Day Range
$18.38
$18.39
52-Week Range
$8.62
$20.78
Volume
1
50D / 200D Avg
$17.91
/
$13.07
Prev Close
$18.38
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 18.0 | 0.2 |
| P/B | 4.7 | 3.0 |
| ROE % | 38.8 | 3.6 |
| Net Margin % | 5.8 | 3.8 |
| Rev Growth 5Y % | 9.2 | 9.9 |
| D/E | 0.9 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$1.73
$1.65 – $1.83
|
2.50B | 1 |
| FY2027 |
$1.49
$1.42 – $1.57
|
2.39B | 1 |
| FY2026 |
$1.27
$1.21 – $1.34
|
2.20B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | $0.26 | $0.21 | -21.3% |
| 2025-08-06 | $0.13 | $0.27 | +104.8% |
| 2025-05-06 | $0.11 | $0.12 | +8.6% |
| 2025-02-27 | $0.12 | $0.15 | +21.5% |
| 2024-11-12 | N/A | $0.14 | — |
| 2024-08-12 | N/A | $0.20 | — |
| 2024-05-15 | N/A | $0.10 | — |
| 2024-03-08 | N/A | $0.07 | — |
Dividend History
7 yr streakYield
0.02%
Payout Ratio
0.43%
Growth (3Y)
-0.85%
Growth (5Y)
-0.01%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Apr 15, 2026 | $0.03 | 2.00% |
| Feb 27, 2026 | Mar 16, 2026 | $0.03 | 1.84% |
| Jan 30, 2026 | Feb 16, 2026 | $0.03 | 2.10% |
| Dec 31, 2025 | Jan 15, 2026 | $0.03 | 2.30% |
| Nov 28, 2025 | Dec 15, 2025 | $0.03 | 2.43% |
| Oct 31, 2025 | Nov 17, 2025 | $0.03 | 3.07% |
| Sep 29, 2025 | Oct 15, 2025 | $0.03 | 3.24% |
| Aug 29, 2025 | Sep 15, 2025 | $0.03 | 3.70% |
| Jul 31, 2025 | Aug 15, 2025 | $0.03 | 3.93% |
| Jun 30, 2025 | Jul 15, 2025 | $0.03 | 3.37% |
| May 30, 2025 | Jun 16, 2025 | $0.03 | 3.31% |
| Apr 30, 2025 | May 15, 2025 | $0.03 | 3.52% |
| Mar 31, 2025 | Apr 15, 2025 | $0.03 | 3.78% |
| Feb 28, 2025 | Mar 17, 2025 | $0.03 | 3.95% |
| Jan 31, 2025 | Feb 14, 2025 | $0.03 | 4.76% |
| Dec 31, 2024 | Jan 15, 2025 | $0.03 | 4.81% |
| Nov 29, 2024 | Dec 16, 2024 | $0.03 | 4.66% |
| Oct 31, 2024 | Nov 15, 2024 | $0.03 | 5.30% |
| Sep 27, 2024 | Oct 15, 2024 | $0.03 | 5.12% |
| Aug 30, 2024 | Sep 16, 2024 | $0.03 | 5.50% |
Key Takeaways
Revenue grew 9.19% annually over 5 years — modest growth
Earnings grew 28.41% over the past year
ROE of 38.83% indicates high profitability
Generating 63.35M in free cash flow
PEG of 0.83 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.96%
Growth
Revenue Growth (5Y)
9.19%
Revenue (1Y)13.15%
Earnings (1Y)28.41%
FCF Growth (3Y)N/A
Quality
Return on Equity
38.83%
ROIC14.49%
Net Margin5.82%
Op. Margin8.33%
Safety
Debt / Equity
0.92
Current Ratio1.37
Interest Coverage7.20
Valuation
P/E Ratio
17.98
Forward P/E14.49
P/B Ratio4.65
EV/EBITDA12.51
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.15% | Revenue Growth (3Y) | 12.75% |
| Earnings Growth (1Y) | 28.41% | Earnings Growth (3Y) | 68.58% |
| Revenue Growth (5Y) | 9.19% | Earnings Growth (5Y) | 70.22% |
| Profitability | |||
| Revenue (TTM) | 1.66B | Net Income (TTM) | 96.58M |
| ROE | 38.83% | ROA | 9.06% |
| Gross Margin | 12.02% | Operating Margin | 8.33% |
| Net Margin | 5.82% | Free Cash Flow (TTM) | 63.35M |
| ROIC | 14.49% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.92 | Current Ratio | 1.37 |
| Interest Coverage | 7.20 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | 0.43% |
| Dividend Growth (3Y) | -0.85% | Dividend Growth (5Y) | -0.01% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 17.98 | Forward P/E | 14.49 |
| P/B Ratio | 4.65 | P/S Ratio | 1.05 |
| PEG Ratio | 0.83 | Forward PEG | N/A |
| EV/EBITDA | 12.51 | Fwd EV/EBITDA | 10.03 |
| Forward P/S | 0.79 | Fwd Earnings Yield | 6.90% |
| FCF Yield | 3.65% | ||
| Market Cap | 1.74B | Enterprise Value | 1.73B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.66B | 1.47B | 1.30B | 1.22B | 1.17B |
| Net Income | 96.58M | 75.21M | 33.98M | 69.55M | 11.50M |
| EPS (Diluted) | 1.11 | 0.86 | 0.40 | -0.05 | 0.11 |
| Gross Profit | 199.43M | 1.47B | 167.62M | 76.83M | 115.61M |
| Operating Income | 138.25M | 111.21M | 111.79M | 20.99M | 63.18M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.07B | 719.79M | 672.73M | 781.58M | 900.32M |
| Total Liabilities | 692.58M | 595.44M | 584.81M | 680.88M | 798.40M |
| Shareholders' Equity | 373.07M | 124.35M | 87.92M | 100.70M | 101.92M |
| Total Debt | 342.65M | 292.49M | 334.52M | 383.97M | 536.85M |
| Cash & Equivalents | 348.90M | 121.85M | 75.18M | 167.28M | 104.63M |
| Current Assets | 451.57M | 243.70M | 187.14M | 258.04M | 224.92M |
| Current Liabilities | 329.91M | 292.88M | 226.39M | 274.99M | 281.91M |
Strategy Scores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#211 of 327
Custom
Balanced Risk
#109 of 153
Custom
Lower Risk
#136 of 141
Recent Activity
Entered
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Entered
Balanced Risk
Mar 24, 2026
Entered
Lower Risk
Mar 24, 2026